Osaka Metropolitan University scientists identified about 140,000 molecular clouds in the Milky Way Galaxy from large-scale data of carbon monoxide molecules, observed in detail by the Nobeyama 45-m radio telescope. Using AI, the researchers estimated the distance of each of these molecular clouds to determine their size and mass, successfully mapping the distribution of the molecular clouds in the Galaxy in the most detailed manner to date.

Stars are formed by molecular gas and dust coalescing in space. These molecular gases are so dilute and cold that they are invisible to the human eye, but they do emit faint radio waves that can be observed by radio telescopes.

Observing from Earth, a lot of matter lies ahead and behind these molecular clouds and these overlapping features m...

A new ‘hybrid’ hydrogel, which allows clinicians to safely deliver stem cells to the site of a brain injury in mice, has been developed by researchers from the University of Melbourne and the Australian National University.

A hydrogel is a water-based gel that can be used to deliver substances into the body and can be used to promote the effective growth of new cells.

Published in Nature Communications, the proof-of-concept breakthrough solves a major challenge faced by stem cell researchers since the 1980s – keeping stem cells alive for long enough to allow them to evolve into the c...

Scientists have detected the heaviest and youngest infant star ever discovered close to the black hole at the center of our Galaxy. They also identified the region where this ‘impossible star’ may have formed.

An international team of researchers under the leadership of Dr Florian Peißker at the University of Cologne’s Institute of Astrophysics has discovered a very young star in its formation phase near the supermassive black hole Sagittarius A* (Sgr A) at the centre of our Milky Way...

Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently available drugs have little effect on many patients. Using so-called digital twins, researchers at Karolinska Institutet have now obtained a deeper understanding of the “off and on” proteins that control these diseases...